Five-year Follow-up of Trial of Replication-competent Adenovirus-mediated Suicide Gene Therapy for Treatment of Prostate Cancer
Open Access
- 1 March 2007
- journal article
- clinical trial
- Published by Elsevier in Molecular Therapy
- Vol. 15 (3), 636-642
- https://doi.org/10.1038/sj.mt.6300068
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- A Phase I Trial of Intravenous CG7870, a Replication-Selective, Prostate-Specific Antigen–Targeted Oncolytic Adenovirus, for the Treatment of Hormone-Refractory, Metastatic Prostate CancerMolecular Therapy, 2006
- Second-Generation Replication-Competent Oncolytic Adenovirus Armed with Improved Suicide Genes and ADP Gene Demonstrates Greater Efficacy without Increased ToxicityMolecular Therapy, 2006
- Preoperative PSA Velocity Is an Independent Prognostic Factor for Relapse After Radical ProstatectomyJournal of Clinical Oncology, 2005
- Phase I Dose Escalation Clinical Trial of Adenovirus Vector Carrying Osteocalcin Promoter-Driven Herpes Simplex Virus Thymidine Kinase in Localized and Metastatic Hormone-Refractory Prostate CancerHuman Gene Therapy, 2003
- Determinants of Prostate Cancer–Specific Survival After Radiation Therapy for Patients With Clinically Localized Prostate CancerJournal of Clinical Oncology, 2002
- Double Suicide Gene Therapy Augments the Antitumor Activity of a Replication-Competent Lytic Adenovirus through Enhanced Cytotoxicity and RadiosensitizationHuman Gene Therapy, 2000
- In Situ Gene Therapy for Adenocarcinoma of the Prostate: A Phase I Clinical TrialHuman Gene Therapy, 1999
- A Novel Three-Pronged Approach to Kill Cancer Cells Selectively: Concomitant Viral, Double Suicide Gene, and RadiotherapyHuman Gene Therapy, 1998
- Linear regressive analysis using prostate-specific antigen doubling time for predicting tumor biology and clinical outcome in prostate cancerCancer, 1993
- ADENOVIRUSES IN HUMAN CANCERThe Lancet, 1972